Seeber et al (27) suggested that perinecrotic HIF-1α expression was significantly associated with a shorter disease-free survival compared with diffuse HIF-1α expression in endometrioid endometrial carcinoma. This evidence concerns the gene HIF1A and endometrial endometrioid carcinoma.